Benzinga | Aug 14, 2020 07:34AM EDT

Cancer Genetics Q2 EPS $(0.82) Down From $(0.01) YoY, Sales $1.40M Down From $1.52M YoY

Cancer Genetics (NASDAQ:CGIX) reported quarterly losses of $(0.82) per share. This is a 8100 percent decrease over losses of $(0.01) per share from the same period last year. The company reported $1.40 million in sales this quarter. This is a 8.20 percent decrease over sales of $1.52 million the same period last year.